Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock (NQ:RAIN)

4.970 -0.040 (-0.80%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Pathos AI Completes Acquisition of Rain Oncology
From Pathos AI, Inc.
Via Business Wire
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
Rain Oncology Inc (NASDAQ: RAIN) has agreed to be acquired by Pathos AI Inc. 
Via Benzinga
Topics Artificial Intelligence
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Rain Oncology Inc. (NASDAQ:RAIN) Long Term Investor Notice: Investigation over Possible Wrongdoing
San Diego, CA -- (SBWIRE) -- 10/19/2023 -- An investigation was announced for current long-term investors in shares of Rain Oncology Inc. (NASDAQ:RAIN) concerning potential breaches of fiduciary duties... 
Via SBWire
Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying
The Dow Jones closed slightly higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
WHY: NEW YORK, NY - (NewMediaWire) - September 12, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021... 
Via TheNewswire.com
Topics Lawsuit
RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
From The Law Offices of Frank R. Cruz
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 175 companies set new 52-week lows. 
Via Benzinga
RAIN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – RAIN
From The Rosen Law Firm PA
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 283 companies set new 52-week lows. 
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
NASDAQ: RAIN Investor Alert: Deadline on September 12, 2023 in Lawsuit Against Rain Oncology Inc.
San Diego, CA -- (SBWIRE) -- 09/06/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 12, 2023 in the lawsuit filed for certain investors of Rain Oncology Inc.... 
Via SBWire
Topics Lawsuit
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
ROSEN, A LEADING NATIONAL FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, and Rain and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rain, Proterra, and Danaher and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAIN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAIN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
RAIN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
RAIN LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, FIRM Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAIN
WHY: NEW YORK, NY - (NewMediaWire) - August 20, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and... 
Via NewMediaWire
Topics Lawsuit
ROSEN, TRUSTED INVESTOR COUNSEL, FIRM Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
From The Rosen Law Firm PA
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.